Elizabeth H.Z. Thompson's Insider Trades & SAST Disclosures
Elizabeth H.Z. Thompson's most recent trade in IGM Biosciences Inc was a trade of 1,452 Common Stock done . Disclosure was reported to the exchange on Dec. 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Elizabeth H.Z. Thompson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IGM Biosciences Inc | Elizabeth H.Z. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 1,452 | 5,808 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Elizabeth H.Z. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 1,452 | 4,356 (0%) | 0% | 0 | Common Stock | |
| Acadia Pharmaceuticals Inc | Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 324,582 | 324,582 | - | - | Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 64,544 | 64,544 | - | - | Restricted Stock Units | |
| IGM Biosciences Inc | Elizabeth H.Z. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 1,452 | 2,904 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Elizabeth H.Z. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 1,452 | 1,452 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Elizabeth H.Z. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 29,400 | 29,400 | - | - | Stock Option (right to buy) | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Mar 2023 | 2,000 | 14,575 (0%) | 0% | 0 | Common Stock | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 20,697 | 20,697 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 19,055 | 26,024 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.80 per share. | 30 Dec 2022 | 9,449 | 16,575 (0%) | 0% | 113.8 | 1,075,296 | Ordinary Shares |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 7,257 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 7,141 | 14,283 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 4,657 | 4,657 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 19 Jul 2022 | 5,917 | 6,969 (0%) | 0% | 85 | 502,945 | Ordinary Shares |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Sale of securities on an exchange or to another person at price $ 85.04 per share. | 19 Jul 2022 | 82 | 12,886 (0%) | 0% | 85.0 | 6,973 | Ordinary Shares |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 19 Jul 2022 | 8 | 12,968 (0%) | 0% | 85 | 680 | Ordinary Shares |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Sale of securities on an exchange or to another person at price $ 85.01 per share. | 07 Jul 2022 | 82 | 12,976 (0%) | 0% | 85.0 | 6,971 | Ordinary Shares |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Sale of securities on an exchange or to another person at price $ 115.64 per share. | 18 Apr 2022 | 8,098 | 13,058 (0%) | 0% | 115.6 | 936,453 | Ordinary Shares |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 21,424 | 21,424 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 13,999 | 28,186 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 7,257 | 7,257 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.84 per share. | 04 Jan 2022 | 7,030 | 21,156 (0%) | 0% | 101.8 | 715,935 | Ordinary Shares |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 4,657 | 9,314 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 2,085 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Sale of securities on an exchange or to another person at price $ 106.34 per share. | 05 Aug 2021 | 7,542 | 14,187 (0%) | 0% | 106.3 | 802,025 | Ordinary Shares |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 12,077 | 27,717 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 12,077 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Elizabeth H.Z. Thompson | EVP, Research & Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.59 per share. | 01 Jul 2021 | 5,988 | 21,729 (0%) | 0% | 96.6 | 578,381 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges